Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.113461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Sarah Asemota und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, US Department of Defense.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is an aggressive subtype with no targeted therapeutics. The luminal androgen receptor (LAR) subtype constitutes 15% of TNBC and is enriched for androgen receptor (AR) and AR target genes. Here, we show that a cohort of TNBC not only expresses AR at a much higher rate (∼80%) but also expresses AR splice variants (AR-SVs) (∼20%), further subclassifying LAR-TNBC. Higher AR and AR-SV expression and corresponding aggressive phenotypes are observed predominantly in specimens obtained from African American women. LAR TNBC specimens are enriched for interferon, Janus kinase (JAK)-signal activator and transducer (STAT), and androgen signaling pathways, which are exclusive to AR-expressing epithelial cancer cells. AR- and AR-SV-expressing TNBC cell proliferation and xenograft and patient-tumor explant growth are inhibited by AR N-terminal domain-binding selective AR degrader or by a JAK inhibitor. Biochemical analysis suggests that STAT1 is an AR coactivator. Collectively, our work identifies pharmacologically targetable TNBC subtypes and identifies growth-promoting interaction between AR and JAK-STAT signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
- Department of Surgery, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
- Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8577, Japan.
- Molecular Bioinformatics Core, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
- Department of Pathology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
Förderung
- NCI NIH HHS
- National Cancer Institute
- US Department of Defense
Zitieren
APA
Asemota, S., Effah, W., Young, K. L., Holt, J., Cripe, L., Ponnusamy, S., Thiyagarajan, T., Hwang, D. J., He, Y., Mcnamara, K., Johnson, D., Wang, Y., Grimes, B., Khosrosereshki, Y., Hollingsworth, T. J., Fleming, M. D., Pritchard, F. E., Hendrix, A., Khan, F., …, & Narayanan, R. (2023). Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113461
Vancouver
Asemota S, Effah W, Young KL, Holt J, Cripe L, Ponnusamy S, et al. Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113461
BibTeX
@article{Asemota2023,
author = {Asemota, Sarah and Effah, Wendy and Young, Kirsten L and Holt, Jeremiah and Cripe, Linnea and Ponnusamy, Suriyan and Thiyagarajan, Thirumagal and Hwang, Dong-Jin and He, Yali and Mcnamara, Keely and Johnson, Daniel and Wang, Yinan and Grimes, Brandy and Khosrosereshki, Yekta and Hollingsworth, T J and Fleming, Martin D and Pritchard, Frances E and Hendrix, Ashley and Khan, Farhan and Fan, Meiyun and Makowski, Liza and Yin, Zheng and Sasano, Hironobu and Hayes, D Neil and Pfeffer, Lawrence M and Miller, Duane D and Narayanan, Ramesh},
title = {Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.113461}
}
EUVIMED